InvestorsHub Logo
Followers 19
Posts 3820
Boards Moderated 0
Alias Born 09/23/2014

Re: Honeycomb777 post# 128505

Tuesday, 06/15/2021 9:47:14 PM

Tuesday, June 15, 2021 9:47:14 PM

Post# of 140474
So you are absolutely right and it is logical to think that upon prototype delivery (Milestone 4) that another agreement is put in place that involves equity position to help Titan and Enos and the prototype thru regulatory, clinical trials and commercialization.

I imagine that Medtronic or any big medtech company (JNJ, Stryker, etc) would ALL WANT TO BE INVOLVED in the regulatory and clinical process. There is too much valuable data that comes from any clinical trial that can be collected and utilized in the commercialization of the product. To think they wouldn't want oversight is niave.

That's why in this robotic space, these companies, like Titan, will be "accounted" for before they are put in human clinical trials. If they don't get accounted for, like a TRXC, then its just a long uphill battle with no upside to investors b/c they don't have technology that is worth premium dollars from the big medtech players.